Back to dashboard
All PlansCoverageMedium impact

Fecal Analysis in the Diagnosis of Intestinal Dysbiosis

Blue Cross & Blue Shield of Mississippi·Gastroenterology, Family Medicine, Internal Medicine·Medical Policy
Effective date
Feb 7, 2025
We identified it
Jun 20, 2026
Days to comply
—

Summary

This policy clarifies that all fecal analysis components for diagnosing intestinal dysbiosis, irritable bowel syndrome, malabsorption, or bacterial overgrowth remain investigational and non-covered. The policy was reviewed with no changes to coverage determinations.

Action Required

Action needed
Immediately: Billing team must ensure all listed fecal analysis CPT codes (0430U, 82239, 82240, 82705, 82710, 82715, 82725, 82726, 82784, 83630, 83631, 83986, 83993, 84311, 84490, 86403, 87045, 87075, 87106, 87177, 87335, 88313, 89125, 89160) are flagged as investigational/non-covered in billing systems for intestinal dysbiosis, IBS, malabsorption, or SIBO diagnoses. Claims will be denied as investigational services.

Affected Billing Codes

82239
82240
82705
82710
82715
82725
82726
82784
83630
83631
83986
83993
84311
84490
86403
87045
87075
87106
87177
87335
88313
89125
89160

Related policy hubs